Latest BVCF Stories
HAYWARD, California and SHANGHAI, Jan. 9, 2015 /PRNewswire/ -- DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund).
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.